Cargando…
Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)
Novel l-valinate amide benzoxaboroles and analogues were designed and synthesized for a structure-activity-relationship (SAR) investigation to optimize the growth inhibitory activity against Trypanosoma congolense (T. congolense) and Trypanosoma vivax (T. vivax) parasites. The study identified 4-flu...
Autores principales: | Akama, Tsutomu, Zhang, Yong-Kang, Freund, Yvonne R., Berry, Pamela, Lee, Joanne, Easom, Eric E., Jacobs, Robert T., Plattner, Jacob J., Witty, Michael J., Peter, Rosemary, Rowan, Tim G., Gillingwater, Kirsten, Brun, Reto, Nare, Bakela, Mercer, Luke, Xu, Musheng, Wang, Jiangong, Liang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720837/ https://www.ncbi.nlm.nih.gov/pubmed/29169674 http://dx.doi.org/10.1016/j.bmcl.2017.11.028 |
Ejemplares similares
-
SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
por: Jacobs, Robert T., et al.
Publicado: (2011) -
Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis
por: WRING, STEPHEN, et al.
Publicado: (2014) -
The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing
por: Begolo, Daniela, et al.
Publicado: (2018) -
Benzoxaborole Antimalarial
Agents. Part 4. Discovery
of Potent 6-(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles
por: Zhang, Yong-Kang, et al.
Publicado: (2015) -
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
por: Lunde, Christopher S., et al.
Publicado: (2019)